latanoprost 0.005% eye drops

DRUG3 trials

Sponsors

Allergan, ViSci Ltd.

Conditions

GlaucomaOcular HypertensionOpen Angle Glaucoma

Phase 1

A Phase 1/2 Multicenter, Randomized, Study to Evaluate the Safety and Efficacy of VS101 Subconjunctival Latanoprost Insert in Subjects With Open-Angle Glaucoma or Ocular Hypertension

CompletedNCT02129673

ViSci Ltd.Ocular Hypertension, Open Angle Glaucoma

Start: 2014-05-31End: 2017-08-31Updated: 2018-03-14

Phase 4

Evaluation of Hyperemia With the Use of Ocular Prostaglandin Analogues

CompletedNCT00539526

AllerganOcular Hypertension, Open Angle Glaucoma

Start: 2007-09-30End: 2008-09-30Updated: 2019-04-24

Safety and Efficacy of Bimatoprost Compared With Latanoprost in Patients With Glaucoma or Ocular Hypertension

CompletedNCT00541242

AllerganGlaucoma, Ocular Hypertension

Start: 2007-12-31End: 2008-08-31Updated: 2011-10-27